comparemela.com

Io Tkis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Considerations in Advanced RCC Treatment Selection

Pedro Barata, MD, MSc, and Benjamin Garmezy, MD, outline factors taken into consideration when selecting advanced RCC treatments.

United statesBenjamin garmezyPedro barataSloan ketteringMemorial sloan ketteringAfrican americanRenal cell carcinomaIo tkisRcc risk stratificationImdc risk scoreNon clear cell rccClear cell rcc

Patient Profile: A 67-Year-Old Man With Metastatic Clear Cell RCC

Benjamin Garmezy, MD, presents the case of a 67-year-old man diagnosed with advanced renal cell carcinoma.

Pedro barataBenjamin garmezyRenal cell carcinomaMetastatic clear cell rccImdc intermediate riskImdc risk scoreDoublet immunotherapyIo tkisClear trial

Front Line Trials in Advanced RCC

Renal cell carcinoma experts discuss clinical trials, evaluating immunotherapies and tyrosine kinase inhibitors in the front line setting of advanced RCC.

Benjamin garmezyPedro barataRenal cell carcinomaClear trialCheckmate 9erKeynote 426Checkmate 214Io tkis

vimarsana © 2020. All Rights Reserved.